Yuk M Law
Affiliation: University of Washington
- Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimensYuk M Law
Department of Pediatrics, Doernbecher Children s Hospital, Oregon Health and Science University, Portland, Oregon 97239, USA
J Heart Lung Transplant 25:276-82. 2006..Controversy exists over the pattern of lipidemic effects from calcineurin inhibitors and prednisone. We report an extensive longitudinal study of lipid profiles in pediatric thoracic transplant recipients...
- Clinically significant thrombosis in pediatric heart transplant recipients during their waiting periodYuk M Law
Department of Pediatrics, Seattle Children s Hospital, University of Washington, 4800 Sand Point Way NE, G 0039, Seattle, WA 98105, USA
Pediatr Cardiol 34:334-40. 2013..Until randomized clinical trial data are available, it may be reasonable to consider anticoagulation for children admitted with decompensated heart failure and listed as UNOS status 1...
- Cardiopulmonary manifestations of portovenous shunts from congenital absence of the portal vein: pulmonary hypertension and pulmonary vascular dilatationY M Law
Department of Pediatrics, Seattle Children s Hospital, Seattle, Washington 98105, USA
Pediatr Transplant 15:E162-8. 2011..These cases illustrate associations that must be entertained in the setting of heterotaxy syndrome, cyanosis, or pulmonary hypertension and how strategic medical combined with surgical management can provide a good outcome...
- Pathophysiology and diagnosis of allograft rejection in pediatric heart transplantationYuk M Law
Pediatric Cardiology, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
Curr Opin Cardiol 22:66-71. 2007..Attempts at improving diagnostic monitoring of allograft rejection continue at a steady pace. The main issue remains whether these methods will replace the standard method of tissue histology from endomyocardial biopsy...
- Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! StudyYuk M Law
Pediatric Cardiology, Department of Pediatrics, Children s Hospital and Regional Medical Center, University of Washington, Seattle, Washington 98105, USA
J Am Coll Cardiol 54:1467-75. 2009..The purpose of this study was to assess the ability of plasma B-type natriuretic peptide (BNP) to diagnose significant cardiovascular disease (CVD) in the pediatric population...
- Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional studyBrian Feingold
Pediatric Cardiology, Children s Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15224, USA
Pediatr Transplant 15:699-705. 2011..Decreased eGFR at one yr post-HTx, but not at HTx, predicts onset of late renal dysfunction. Future research on strategies to minimize late renal dysfunction after pediatric HTx may be of greatest benefit if focused on these subgroups...
- Mitochondrial electron transport chain deficiency, cardiomyopathy, and long-term cardiac transplant outcomeAlana S Golden
Division of Pediatric Neurology, Seattle Children s Hospital and University of Washington, Seattle, WA 98105, USA
Pediatr Transplant 16:265-8. 2012..Our results suggest that with proper patient selection in this population, cardiac transplantation is feasible and can have good outcomes...
- Nesiritide use in pediatric patients with congestive heart failureBrian Feingold
Division of Cardiology, Department of Pediatrics, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA
J Heart Lung Transplant 23:1455-9. 2004....
- Long-term comparison of tacrolimus- and cyclosporine-induced nephrotoxicity in pediatric heart-transplant recipientsRobert F English
Division of Pediatric Cardiology, Children s Hospital of Pittsburgh, USA
Am J Transplant 2:769-73. 2002..We conclude that the nephrotoxicities of tacrolimus and cyclosporine are comparable over the medium- to long-term in pediatric heart-transplant recipients...